1 September 2024 false Taxfiler 2024.6 10314240 business:PrivateLimitedCompanyLtd 2024-09-01 2025-11-30 10314240 2024-08-31 10314240 2024-09-01 2025-11-30 10314240 business:AuditExemptWithAccountantsReport 2024-09-01 2025-11-30 10314240 business:AbridgedAccounts 2024-09-01 2025-11-30 10314240 2025-11-30 10314240 2024-08-31 10314240 core:WithinOneYear 2025-11-30 10314240 core:WithinOneYear 2024-08-31 10314240 core:ShareCapital core:PreviouslyStatedAmount 2025-11-30 10314240 core:ShareCapital core:PreviouslyStatedAmount 2024-08-31 10314240 core:RetainedEarningsAccumulatedLosses core:PreviouslyStatedAmount 2025-11-30 10314240 core:RetainedEarningsAccumulatedLosses core:PreviouslyStatedAmount 2024-08-31 10314240 core:PreviouslyStatedAmount 2025-11-30 10314240 core:PreviouslyStatedAmount 2024-08-31 10314240 business:SmallEntities 2024-09-01 2025-11-30 10314240 business:Director1 2024-09-01 2025-11-30 10314240 countries:EnglandWales 2024-09-01 2025-11-30 10314240 business:RegisteredOffice 2024-09-01 2025-11-30 10314240 core:PlantMachinery 2024-09-01 2025-11-30 10314240 core:ComputerEquipment 2024-09-01 2025-11-30 10314240 2023-09-01 2024-08-31 iso4217:GBP xbrli:pure
Company Registration No. 10314240 (England and Wales)
MB Med Ltd Unaudited accounts for the period from 1 September 2024 to 30 November 2025
MB Med Ltd Statement of financial position as at 30 November 2025
2025
2024
Notes
£
£
Fixed assets
Tangible assets
4
1,343
1,791
Current assets
Debtors
-
152
Cash at bank and in hand
16,137
15,972
16,137
16,124
Creditors: amounts falling due within one year
(8,516)
(12,108)
Net current assets
7,621
4,016
Total assets less current liabilities
8,964
5,807
Provisions for liabilities
Deferred tax
(47)
(47)
Net assets
8,917
5,760
Capital and reserves
Called up share capital
10
10
Profit and loss account
8,907
5,750
Shareholders' funds
8,917
5,760
For the period ending 30 November 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
The members have agreed to the preparation of abridged accounts for the period in accordance with Section 444(2A).
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board and authorised for issue on 10 February 2026 and were signed on its behalf by
Dr Mariam Bibi Director Company Registration No. 10314240
- 2 -
MB Med Ltd Notes to the Accounts for the period from 1 September 2024 to 30 November 2025
1
Statutory information
MB Med Ltd is a private company, limited by shares, registered in England and Wales, registration number 10314240. The registered office is 409 Bradford Road, Huddersfield, HD2 2RB , United Kingdom.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
3
Accounting policies
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous period, and also have been consistently applied within the same accounts.
Basis of preparation
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
Presentation currency
The accounts are presented in £ sterling.
Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. Turnover from the sale of goods is recognised when goods have been delivered to customers such that risks and rewards of ownership have transferred to them. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Tangible fixed assets and depreciation
Tangible assets are included at cost less depreciation and impairment. Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives:
Plant & machinery
25%
Computer equipment
25%
Deferred taxation
Deferred tax arises as a result of including items of income and expenditure in taxation computations in periods different from those in which they are included in the company's accounts. Deferred tax is provided in full on timing differences which result in an obligation to pay more (or less) tax at a future date, at the average tax rates that are expected to apply when the timing differences reverse, based on current tax rates and laws. Deferred tax assets and liabilities are not discounted.
- 3 -
MB Med Ltd Notes to the Accounts for the period from 1 September 2024 to 30 November 2025
4
Tangible fixed assets
Total
£
Cost or valuation
At 1 September 2024
4,595
At 30 November 2025
4,595
Depreciation
At 1 September 2024
2,804
Charge for the period
448
At 30 November 2025
3,252
Net book value
At 30 November 2025
1,343
At 31 August 2024
1,791
5
Average number of employees
During the period the average number of employees was 1 (2024: 1).
- 4 -